CAV1 and neoplasm: Contrastingly, Cav1 is downregulated in oncogenically transformed cells, but then upregulated again in later tumor stages to potentially support tumor invasion and drug resistance, which has been demonstrated in prostate cancer [19,20,21,22,23].